BOWMAN A BLAINE 4
4 · Personalis, Inc. · Filed May 14, 2026
Research Summary
AI-generated summary of this filing
Personalis (PSNL) Director Bowman A. Blaine Receives RSU and Option Grants
What Happened
Bowman A. Blaine, a director of Personalis, Inc. (PSNL), received equity awards on 2026-05-12: 6,250 restricted stock units (RSUs) and a 37,500-share derivative award (an option-style grant). Both grants were reported with an acquisition price of $0, meaning they were awarded to Blaine rather than purchased. These are grants/awards (code A) — not sales or exercised options — and thus are compensation/retention awards rather than market purchases.
Key Details
- Transaction date: 2026-05-12; Form 4 filed 2026-05-14 (filed within the standard two-business-day window).
- Grants: 6,250 RSUs @ $0 (total $0); 37,500 derivative (option) units @ $0 (total $0).
- Vesting (RSU): 100% vests on the earlier of one year after grant or the day before the next annual meeting, subject to continuous service; immediate vesting if a Change in Control occurs (footnote F1).
- Vesting (option/derivative): 100% vests on the earlier of one year after grant or the day before the next annual meeting, subject to continuous service; in a Change in Control the option vests and becomes exercisable immediately prior to such event (footnote F2).
- Shares owned after the transaction: Not disclosed in the filing.
- Filing timeliness: Reported on 2026-05-14 for a 2026-05-12 grant—timely under Form 4 rules.
Context
- RSUs are a promise to deliver shares upon vesting; the derivative award appears to be an option-style grant that must vest before it can be exercised into shares. Neither award was exercised or sold at the time of this filing.
- Grants at $0 are common for director and executive compensation and do not represent a cash purchase; they are intended for retention/incentive.
- These awards are informational about insider compensation and do not, by themselves, indicate buying or selling sentiment.
Insider Transaction Report
Form 4
Personalis, Inc.PSNL
BOWMAN A BLAINE
Director
Transactions
- Award
Common Stock
[F1]2026-05-12+6,250→ 19,756 total - Award
Stock Option (right to buy)
[F2]2026-05-12+37,500→ 37,500 totalExercise: $6.04Exp: 2036-05-12→ Common Stock (37,500 underlying)
Footnotes (2)
- [F1]Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 100% of the shares subject to the RSU shall vest on the earlier of the one-year anniversary of the grant date or the day prior to the Company's next annual meeting of stockholders occurring after the grant date, subject to the reporting person's Continuous Service (as defined in the Company's 2019 Equity Incentive Plan (the "2019 Plan")) through the vesting date. In the event of a Change in Control (as defined in the 2019 Plan), the shares underlying the RSU shall vest immediately prior to the effectiveness of such Change in Control.
- [F2]100% of the shares subject to the option shall vest on the earlier of the one-year anniversary of the grant date or the day prior to the Company's next annual meeting of stockholders occurring after the grant date, subject to the reporting person's Continuous Service (as defined in the 2019 Plan) through the vesting date. In the event of a Change in Control (as defined in the 2019 Plan), the shares underlying the option shall vest and become exercisable immediately prior to the effectiveness of such Change in Control.
Signature
/s/ Aaron Tachibana, Attorney-in-Fact|2026-05-14